These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 15741991)
1. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991 [TBL] [Abstract][Full Text] [Related]
2. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Coffee B; Zhang F; Ceman S; Warren ST; Reines D Am J Hum Genet; 2002 Oct; 71(4):923-32. PubMed ID: 12232854 [TBL] [Abstract][Full Text] [Related]
3. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Coffee B; Zhang F; Warren ST; Reines D Nat Genet; 1999 May; 22(1):98-101. PubMed ID: 10319871 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Chiurazzi P; Pomponi MG; Pietrobono R; Bakker CE; Neri G; Oostra BA Hum Mol Genet; 1999 Nov; 8(12):2317-23. PubMed ID: 10545613 [TBL] [Abstract][Full Text] [Related]
5. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243 [TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of the events leading to inactivation of the FMR1 gene. Pietrobono R; Tabolacci E; Zalfa F; Zito I; Terracciano A; Moscato U; Bagni C; Oostra B; Chiurazzi P; Neri G Hum Mol Genet; 2005 Jan; 14(2):267-77. PubMed ID: 15563507 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110 [TBL] [Abstract][Full Text] [Related]
8. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. Meng CF; Zhu XJ; Peng G; Dai DQ World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755 [TBL] [Abstract][Full Text] [Related]
9. SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. Biacsi R; Kumari D; Usdin K PLoS Genet; 2008 Mar; 4(3):e1000017. PubMed ID: 18369442 [TBL] [Abstract][Full Text] [Related]
10. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235 [TBL] [Abstract][Full Text] [Related]
11. Epigenetics, fragile X syndrome and transcriptional therapy. Tabolacci E; Chiurazzi P Am J Med Genet A; 2013 Nov; 161A(11):2797-808. PubMed ID: 24123753 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells. Tabolacci E; Mancano G; Lanni S; Palumbo F; Goracci M; Ferrè F; Helmer-Citterich M; Neri G Epigenetics Chromatin; 2016; 9():12. PubMed ID: 27014370 [TBL] [Abstract][Full Text] [Related]
13. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines. Lambrot R; Kimmins S Int J Androl; 2011 Apr; 34(2):110-23. PubMed ID: 20497257 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Kawamoto K; Okino ST; Place RF; Urakami S; Hirata H; Kikuno N; Kawakami T; Tanaka Y; Pookot D; Chen Z; Majid S; Enokida H; Nakagawa M; Dahiya R Clin Cancer Res; 2007 May; 13(9):2541-8. PubMed ID: 17473182 [TBL] [Abstract][Full Text] [Related]
15. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. Mossman D; Scott RJ PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702 [TBL] [Abstract][Full Text] [Related]
16. The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Kumari D; Usdin K Hum Mol Genet; 2010 Dec; 19(23):4634-42. PubMed ID: 20843831 [TBL] [Abstract][Full Text] [Related]
17. The histone code regulating expression of the imprinted mouse Igf2r gene. Yang Y; Li T; Vu TH; Ulaner GA; Hu JF; Hoffman AR Endocrinology; 2003 Dec; 144(12):5658-70. PubMed ID: 12975326 [TBL] [Abstract][Full Text] [Related]
18. Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation. Tabolacci E; De Pascalis I; Accadia M; Terracciano A; Moscato U; Chiurazzi P; Neri G Pharmacogenet Genomics; 2008 Aug; 18(8):738-41. PubMed ID: 18622267 [TBL] [Abstract][Full Text] [Related]
19. In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Chiurazzi P; Pomponi MG; Willemsen R; Oostra BA; Neri G Hum Mol Genet; 1998 Jan; 7(1):109-13. PubMed ID: 9384610 [TBL] [Abstract][Full Text] [Related]